Johnson CHEN

Founder

Mr Chen is the Managing Partner for Clearbridge Partners, an Asian venture capital firm. He is also the Managing Partner for Clearbridge Accelerator, a Singapore National Research Foundation (NRF) backed technology incubator.

Prior to founding Clearbridge, Mr Chen worked at Pacific Century CyberWorks Limited, the incumbent and leading telecommunications company in Hong Kong. Mr Chen is a member of the pioneering team at PCCW and was the President of CyberWorks Ventures, the Venture Capital and direct investment arm of PCCW. Mr Chen was also the youngest member of PCCW's Mergers & Acquisitions executive committee, and was responsible for much of PCCW's strategic expansion and many of its successful acquisitions and investments.

Mr Chen has more than 12 years of entrepreneurship experience with start-ups, being the co-founder of 2 start-up companies: First Cube Pte. Ltd., which has now been majority acquired by Singapore Post, and Property Portal!, which was sold to a Hong Kong listed company. Mr Chen has also given talks on entrepreneurship in Hong Kong and the United States, including the Sloan School of Management at MIT. Mr Chen is an active angel investor and is a member of the Hong Kong Science and Technology Park (HKSTP) incubator selection panel.

Mr Chen is the recipient of the prestigious Sword of Honour from the Singapore Armed Forces, and holds a B.A., M.A. and M.Eng from the University of Cambridge, (U.K.).

LIM Chwee Teck

Founder

Professor Lim Chwee Teck currently holds joint appointments at both the Departments of Bioengineering and Mechanical Engineering at the National University of Singapore (NUS). He is also a Principal Investigator at the Mechanobiology Institute as well as a Fellow of the Singapore-MIT Alliance.  Professor Lim heads the Nano Biomechanics Lab which conducts basic and applied research in cell and molecular biomechanics and mechanobiology of human diseases as well as development of mechanics based label-free micro/nano biomedical devices.

Prof Lim has authored more than 165 journal papers (including 24 invited/review articles and 8 ISI highly cited papers), 16 book chapters and delivered more than 140 plenary/keynote/invited talks. He is currently on the editorial boards of 8 international journals. Prof Lim has recently been elected as a Council Member of the World Council for Biomechanics. He has co-founded 3 start-up companies that exploit inventions that he has developed in his lab.

Prof Lim has won several research awards and honors including the IES Prestigious Engineering Achievement Award, highly cited author award, Best Paper awards and Best Poster awards in international conferences. His research was cited by the MIT Technology Review magazine as one of the top ten emerging technologies of 2006 that will "have a significant impact on business, medicine or culture".

Chee-Wah CHONG

Founder

Mr Chong previously worked as a Communications Security Program Manager at the DSO National Laboratories. He won the prestigious KINETIC Award in DSO for his outstanding technical contributions to various initiatives in the defence sector. He oversaw various cryptographic and communication systems as well as direct research & development investments in excess of S$5 million annually. He was also the key technical decision maker on various national level projects.

Prior to working at DSO, Mr Chong was with the Directorate of Research & Development (under the Defence Science & Technology Agency) as a Country Manager, where he was responsible for the long term strategic R&D plans for the Ministry of Defence. Mr Chong was also the Assistant Director of Finance Policy at the Ministry of Health (MOH) where his responsibilities included policy matters on Singapore's key medical financial schemes.

Mr Chong is the recipient of the Public Service Commission's Local Merit Scholarship and has a B.Eng and M.Eng (Electrical Engineering) from the National University of Singapore.

TAN Swee Jin

Founder

Mr Tan is a one of the rising stars in the field of nanobiomechanics. He is the co-inventor for the Circulating Tumour Cell (CTC) Microfiltration BioChip - an innovative device which allows clinicians to isolate and enumerate circulating tumour cells from whole patient blood and, most impressively, retrieve wholly intact, viable circulating tumour cells.

Mr Tan is a recipient of the A*STAR Graduate Scholarship which is awarded only to the top graduates in the fields of Biomedical Sciences, Physical Sciences and Engineering. He has also won several awards, including the Young Investigator Award at the 6th World Congress on Biomechanics and the prestigious Tan Kah Kee Young Inventors' Award.

The author/co-author of several scientific publications, Mr Tan has been invited to present his work at both local and international conferences, such as the International Conference on Biocomputation, Bioinformatics, and Biomedical Technologies and also at the prestigious National Institutes of Health (NIH), USA.

Mr Tan holds a B.Eng (First Class Honours) and will receive his Ph.D from the National University of Singapore.

Andrew Wu

Project Director

Dr Wu is currently serving as Project Director of Clearbridge Biomedics, overseeing the companies' product and business development.

Previously he had served as the Technical Director of Cordlife Group for over 3 years, and led a teams of technologists from around the region for the management of laboratory and technical operations of Cordlife Group Limited and its associates. Also leading the medical affairs team, Dr Wu was also involved with a series of firsts in cord blood application in Singapore, such as cerebral palsy and neuroblastoma.

Prior to joining the CordLife group of companies, Dr Wu worked for A-Bio Pharma in process development. He holds a Bachelors and a Doctorate in Biochemical Engineering from University College, London.

Ali Asgar Bhagat

Principal Scientist

Dr. Ali Asgar Bhagat received his M.S. (2006) and Ph.D. (2009) in Electrical Engineering from the University of Cincinnati, USA. Following his degree he held Post-doctoral Associate position at Massachusetts Institute of Technology, USA prior to moving to Singapore. Before joining Clearbridge, Dr. Bhagat worked as a Research Scientist in the newly formed Biosystems and Micromechanics (BioSyM) group at the Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore.

Author of over 10 peer-reviewed scientific publications, Dr. Bhagat's research interests lies in developing microfluidics based solutions for efficient cell separation/isolation and applying them towards point-of-care disease diagnostics.